New Drug's first human test: is it safe?
NCT ID NCT06200597
Summary
This early-stage study tested the safety of an experimental drug called LAD603 in healthy adults. Researchers gave 92 participants single or multiple doses to check for side effects and see how the body absorbs and processes the medication. The main goal was to determine safe dosage levels for future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Phase 1 unit Lenexa
Lenexa, Kansas, 66219, United States
Conditions
Explore the condition pages connected to this study.